MEJ-54068-89611
5 vaccinations
1 coded response
19 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 531 / WI
- Registered
- 2021-01-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Registered in v-safe
-
2021-01-05
Dose 1 — Pfizer-BioNTech
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-12
- 2021-01-26
-
2021-01-30
Dose 2 — Pfizer-BioNTech
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-02-27
- 2021-03-06
- 2021-03-15
- 2021-05-03
- 2021-08-02
-
2021-10-19
Dose 3 — Pfizer-BioNTech
-
2022-01-26
Dose 4 — Pfizer-BioNTech
- 2022-02-01
-
2022-09-14
Dose 5 — Pfizer-BioNTechCo-administered: Flu
-
2022-12-16
Survey response — 3 months, dose 5MedDRA: Influenza, Nephrolithiasis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Had influenza a Kidney stonesMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Pfizer-BioNTech | |
| 2 | 2021-01-30 | Pfizer-BioNTech | |
| 3 | 2021-10-19 | Pfizer-BioNTech | No |
| 4 | 2022-01-26 | Pfizer-BioNTech | No |
| 5 | 2022-09-14 | Pfizer-BioNTech | Flu |
Free text
Release 12 — 3 months, dose 5
Symptoms: Had influenza a Kidney stones
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza | · | · | ✓ |
| SD | Nephrolithiasis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release